{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:02:30Z","timestamp":1784257350206,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":33,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"Commission of the European Communities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jtos.2021.12.008","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T21:55:21Z","timestamp":1639605321000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Topical application of cannabinoid-ligands ameliorates experimental dry-eye disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Bao N.","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Maass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen","family":"Musial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Gehlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6892-3619","authenticated-orcid":false,"given":"Philipp","family":"Steven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2021.12.008_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.12.008_bib2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.12.008_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction","volume":"100","author":"Baudouin","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.008_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"The ocular surface TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.12.008_bib5","first-page":"163","article-title":"Management and therapy of dry eye disease: report of the management and therapy subcommittee of the international dry eye WorkShop","volume":"5","author":"Pflugfelder","year":"2012","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.12.008_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/TCRM.S1928","article-title":"Cannabinoids in the management of difficult to treat pain","volume":"4","author":"Russo","year":"2008","journal-title":"Therapeut Clin Risk Manag"},{"key":"10.1016\/j.jtos.2021.12.008_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/can.2017.0041","article-title":"The cannabinoids \u03948THC, CBD, and HU-308 act via distinct receptors to reduce corneal pain and inflammation","volume":"3","author":"Thapa","year":"2018","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jtos.2021.12.008_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.exer.2019.03.011","article-title":"Cannabinoid CB2R receptors are upregulated with corneal injury and regulate the course of corneal wound healing","volume":"182","author":"Murataeva","year":"2019","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2021.12.008_bib9","series-title":"Cannabis sativa and hemp","author":"Hartsel","year":"2016"},{"key":"10.1016\/j.jtos.2021.12.008_bib10","first-page":"54","article-title":"Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs","volume":"26","author":"Gurney","year":"2014","journal-title":"Forensic Sci Rev"},{"key":"10.1016\/j.jtos.2021.12.008_bib11","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.21-10-j0004.2001","article-title":"Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture","volume":"21","author":"Kim","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.jtos.2021.12.008_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.jtos.2021.12.008_bib13","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","article-title":"Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons","volume":"19","author":"Katona","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.jtos.2021.12.008_bib14","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/j.1476-5381.1996.tb15639.x","article-title":"Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves","volume":"118","author":"Ishac","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jtos.2021.12.008_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1254\/jphs.FP0040872","article-title":"CB(1) cannabinoid receptor stimulation modulates transient receptor potential vanilloid receptor 1 activities in calcium influx and substance P Release in cultured rat dorsal root ganglion cells","volume":"97","author":"Oshita","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jtos.2021.12.008_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jtos.2021.12.008_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2916732","article-title":"The endocannabinoid system in the retina: from physiology to practical and therapeutic applications","volume":"2016","author":"Schwitzer","year":"2016","journal-title":"Neural Plast"},{"key":"10.1016\/j.jtos.2021.12.008_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2016.00304","article-title":"Turning down the thermostat: modulating the endocannabinoid system in ocular inflammation and pain","volume":"7","author":"Toguri","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jtos.2021.12.008_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1471-4159.2005.03380.x","article-title":"Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli","volume":"95","author":"Maresz","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.jtos.2021.12.008_bib20","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB2receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jtos.2021.12.008_bib21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.gastro.2005.05.026","article-title":"Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing","volume":"129","author":"Wright","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtos.2021.12.008_bib22","first-page":"632","article-title":"A mouse model of keratoconjunctivitis sicca","volume":"43","author":"Dursun","year":"2002","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.12.008_bib23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00417-016-3572-y","article-title":"A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye","volume":"255","author":"Gehlsen","year":"2017","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.008_bib24","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.4049\/jimmunol.176.7.3950","article-title":"Desiccating stress induces T cell-mediated Sj\u00f6gren\u2019s syndrome-like lacrimal keratoconjunctivitis","volume":"176","author":"Niederkorn","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2021.12.008_bib25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.12.008_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1744-8069-10-26","article-title":"A simplified up-down method (SUDO) for measuring mechanical nociception in rodents using von Frey filaments","volume":"10","author":"Bonin","year":"2014","journal-title":"Mol Pain"},{"key":"10.1016\/j.jtos.2021.12.008_bib27","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/01621459.1965.10480843","article-title":"The up-and-down method for small samples","volume":"60","author":"Dixon","year":"1965","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jtos.2021.12.008_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.exer.2018.01.024","article-title":"Reduced intraepithelial corneal nerve density and sensitivity accompany desiccating stress and aging in C57BL\/6 mice","volume":"169","author":"Stepp","year":"2018","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2021.12.008_bib29","first-page":"93","article-title":"An improved region growing algorithm for image segmentation","volume":"6","author":"Cui","year":"2008"},{"key":"10.1016\/j.jtos.2021.12.008_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.exer.2015.08.023","article-title":"Topical Mitomycin-C enhances subbasal nerve regeneration and reduces erosion frequency in the debridement wounded mouse cornea","volume":"146","author":"Pal-Ghosh","year":"2016","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2021.12.008_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gks596","article-title":"Primer3\u2014new capabilities and interfaces","volume":"40","author":"Untergasser","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtos.2021.12.008_bib32","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/bioinformatics\/btm091","article-title":"Enhancements and modifications of primer design program Primer3","volume":"23","author":"Koressaar","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jtos.2021.12.008_bib33","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C T method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jtos.2021.12.008_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mi.2009.5","article-title":"IL-17 disrupts corneal barrier following desiccating stress","volume":"2","author":"De Paiva","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jtos.2021.12.008_bib35","first-page":"2442","article-title":"Localization of cannabinoid CB1 receptors in the human anterior eye and retina","volume":"40","author":"Straiker","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.12.008_bib36","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1167\/iovs.07-1319","article-title":"Cannabinoid receptors in conjunctival epithelium: identification and functional properties","volume":"49","author":"Iribarne","year":"2008","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.12.008_bib37","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1006\/exer.1996.0265","article-title":"Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues","volume":"64","author":"Matsuda","year":"1997","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2021.12.008_bib38","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.4049\/jimmunol.176.7.3950","article-title":"Desiccating stress induces T cell-mediated Sjogren's syndrome-like lacrimal keratoconjunctivitis","volume":"176","author":"Niederkorn","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2021.12.008_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/08830185.2012.748052","article-title":"Dry eye as a mucosal autoimmune disease","volume":"32","author":"Stern","year":"2013","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.jtos.2021.12.008_bib40","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/ICO.0b013e31816bf46c","article-title":"Interleukin-1 receptor-1-deficientmiceshowattenuated production of ocular surface inflammatory cytokines in experimental dry eye","volume":"27","author":"Narayanan","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.12.008_bib41","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1167\/iovs.15-17627","article-title":"Aqueous tear deficiency increases conjunctival interferon-\u03b3 (IFN-\u03b3) expression and goblet cell loss","volume":"56","author":"Pflugfelder","year":"2015","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.12.008_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1191\/1352458504ms1009oa","article-title":"Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte\/endothelial interactions in an experimental autoimmune encephalomyelitis model","volume":"10","author":"Ni","year":"2004","journal-title":"Mult Scler J"},{"key":"10.1016\/j.jtos.2021.12.008_bib43","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/embor.2010.93","article-title":"Regulation of interleukin-1\u03b2 by interferon-\u03b3 is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production","volume":"11","author":"Masters","year":"2010","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jtos.2021.12.008_bib44","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1167\/iovs.07-0069","article-title":"Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-\u03b3","volume":"48","author":"De Paiva","year":"2007","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.12.008_bib45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ni1063","article-title":"Analysis of regulatory CD8 T cells in Qa-1-deficient mice","volume":"5","author":"Hu","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtos.2021.12.008_bib46","first-page":"243","article-title":"IL-17 disrupts corneal barrier following desiccating stress","volume":"2","author":"Manuscript","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jtos.2021.12.008_bib47","author":"Chauhan"},{"key":"10.1016\/j.jtos.2021.12.008_bib48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2567.2008.02838.x","article-title":"Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide\u2010induced alterations in circulating cytokine levels in rats","volume":"125","author":"Roche","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.jtos.2021.12.008_bib49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1124\/jpet.109.163998","article-title":"Anti-inflammatory properties of CB1-receptor antagonist involves \u03b22 adrenoceptors","volume":"333","author":"Mnich","year":"2010","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.jtos.2021.12.008_bib50","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/jop.2011.0049","article-title":"A cannabinoid ligand, anandamide, exacerbates endotoxin-induced uveitis in rabbits","volume":"27","author":"Altinsoy","year":"2011","journal-title":"J Ocul Pharmacol Therapeut"},{"key":"10.1016\/j.jtos.2021.12.008_bib51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cellsig.2012.10.015","article-title":"Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury","volume":"25","author":"Yang","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.jtos.2021.12.008_bib52","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1167\/iovs.16-20303","article-title":"Safety and efficacy clinical trials for SYL1001, a novel short interfering RNA for the treatment of dry eye disease","volume":"57","author":"Benitez-Del-Castillo","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.12.008_bib53","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1369-1600.2008.00105.x","article-title":"The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction","volume":"13","author":"L\u00f3pez-Moreno","year":"2008","journal-title":"Addiction Biol"},{"key":"10.1016\/j.jtos.2021.12.008_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bjp.0704506","article-title":"CB1 receptor antagonist SR141716A increases capsaicin\u2010evoked release of Substance P from the adult mouse spinal cord","volume":"135","author":"Lever","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jtos.2021.12.008_bib55","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","article-title":"The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions","volume":"138","author":"Tzavara","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jtos.2021.12.008_bib56","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","article-title":"TFOS DEWS II pain and sensation report","volume":"15","author":"Belmonte","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.12.008_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1656-4","article-title":"Chronic dry eye induced corneal hypersensitivity, neuroinflammatory responses, and synaptic plasticity in the mouse trigeminal brainstem","volume":"16","author":"Fakih","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jtos.2021.12.008_bib58","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.ophtha.2017.08.004","article-title":"Neuropathic corneal pain: approaches for management","volume":"124","author":"Dieckmann","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2021.12.008_bib59","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1167\/iovs.15-18133","article-title":"Corneal mechanical thresholds negatively associate with dry eye and ocular pain symptoms","volume":"57","author":"Spierer","year":"2016","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.12.008_bib60","doi-asserted-by":"crossref","first-page":"110794","DOI":"10.1016\/j.biopha.2020.110794","article-title":"Topical treatment with a mu opioid receptor agonist alleviates corneal allodynia and corneal nerve sensitization in mice","volume":"132","author":"Joubert","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jtos.2021.12.008_bib61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40135-019-00214-z","article-title":"Facts vs fiction: the role of cannabinoids in the treatment of glaucoma","volume":"7","author":"Katz","year":"2019","journal-title":"Curr Ophthalmol Rep"},{"key":"10.1016\/j.jtos.2021.12.008_bib62","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbi.2017.10.021","article-title":"Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization","volume":"68","author":"Braun","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jtos.2021.12.008_bib63","doi-asserted-by":"crossref","first-page":"12136","DOI":"10.1523\/JNEUROSCI.3402-08.2008","article-title":"Interferon-\u03b3 is a critical modulator of CB2 cannabinoid receptor signaling during neuropathic pain","volume":"28","author":"Racz","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.jtos.2021.12.008_bib64","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.3390\/jcm9124036","article-title":"CannabinEYEds: the endocannabinoid system as a regulator of the ocular surface nociception, inflammatory response, neovascularization and wound healing","volume":"9","author":"Aiello","year":"2020","journal-title":"J Clin Med"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012421001476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012421001476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:42:41Z","timestamp":1761540161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012421001476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":64,"alternative-id":["S1542012421001476"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2021.12.008","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical application of cannabinoid-ligands ameliorates experimental dry-eye disease","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2021.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}